ELEVANCE HEALTH INC (ELV) Stock Institutional Trading Activity


ELEVANCE HEALTH INC (ELV) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Brave Warrior Advisors, Eagle Capital Management, Baupost Group, Vulcan Value Partners, and Yacktman Asset Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2024Vulcan Value PartnersSell-44,802344,938$186,745
Q2 2024Sequoia Financial AdvisorsBuy2536,328$3,428,912
Q2 2024Hancock Classic ValueSell-964192,255$104,175,294
Q2 2024Sequoia FundSell-50,6141,024,071$554,903,112
Q2 2024Eagle Capital ManagementBuy42,2801,608,516$871,590,480
Q2 2024Brave Warrior AdvisorsSell-12,7101,633,127$884,926,196
Q2 2024First Eagle U.S. ValueBuy275,7082,058,283$1,115,301,464
Q1 2024Yacktman Asset ManagementSell-11,201374,620$194,255,455
Q1 2024Sound Shore ManagementBuy4,713154,643$80,188,581
Q1 2024Renaissance Technologies LLCSell-363,5007,973$4,134
Q1 2024Vulcan Value PartnersBuy5,323389,740$202,037
Q1 2024Sequoia Financial AdvisorsSell-3,8596,075$3,150,362
Q1 2024Hancock Classic ValueSell-331193,219$100,191,780
Q1 2024Sequoia FundSell-46,9581,074,685$557,267,160
Q1 2024Eagle Capital ManagementSell-44,2331,566,236$812,156,015
Q1 2024Brave Warrior AdvisorsSell-110,8161,645,837$853,432,318
Q1 2024First Eagle U.S. ValueBuy4,0881,782,575$924,336,456
Q4 2023Yacktman Asset ManagementSell-1,561385,821$181,937,751
Q4 2023Sound Shore ManagementSell-247149,930$70,700,991
Q4 2023Renaissance Technologies LLCSell-137,300371,473$175,172
Q4 2023Vulcan Value PartnersSell-65,113384,417$181,430
Q4 2023Sequoia Financial AdvisorsBuy5,0479,934$4,684,642
Q4 2023Hancock Classic ValueBuy722193,550$91,270,438
Q4 2023Sequoia FundSell-28,5781,121,643$528,921,973
Q4 2023Eagle Capital ManagementBuy225,9911,610,469$759,432,762
Q4 2023Brave Warrior AdvisorsBuy129,0551,756,653$828,367,289
Q4 2023First Eagle U.S. ValueSell-4,2981,778,487$838,663,419
Q3 2023Yacktman Asset ManagementSell-1,369387,382$168,673,870
Q3 2023Sound Shore ManagementBuy32,790150,177$65,390,069
Q3 2023Vulcan Value PartnersSell-97,288449,530$195,841

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.